BioSource Shows Net Loss; Stock, Staff Moves Cited
- Share via
BioSource International Inc. in Camarillo said third-quarter net sales increased $680,000 or 9.1% to $8.2 million for the three months that ended Sept. 30.
However, the company reported a net loss of $2.9 million, or 35 cents per share. BioSource incurred charges of 28 cents per share for the conversion of preferred stock to common stock, and 13 cents per share in the transition to a new senior management team. Those charges included severance costs of $900,000, stock compensation charges of $600,000 and professional fees of $200,000.
When adjusting for the nonrecurring items, net income for the quarter would have been 6 cents per share, compared with 12 cents per share for the same quarter last year.
BioSource develops biological reagent systems used in pharmaceutical and biomedical research.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
